申请人:Lipha Lyonnaise Industrielle Pharmaceutique
公开号:US04554273A1
公开(公告)日:1985-11-19
Disclosed are 2-amino-5-phenyl-1,3-benzodiazepines of the formula ##STR1## wherein R.sub.1 and R.sub.2 are hydrogen, halogen, alkyl, or alkoxy; R.sub.2 being able to occupy any of the possible positions on the aromatic ring; R.sub.3 is hydrogen or alkyl; and R.sub.4 is hydrogen, alkyl, cycloalkyl, arylalkyl, heteroarylalkyl, dialkylaminoethyl, dialkylaminopropyl, (1-ethyl-2-pyrrolidino) methyl, dialkylamino, alkoxycarbonyl or cyano; or R.sub.3 and R.sub.4 form, with the adjacent nitrogen atom, a heterocycle having 5 to 7 side chains, optionally containing another heteroatom selected from oxygen, sulfur or nitrogen, this latter being able to be substituted by an alkyl group. The majority of the compounds are obtained by condensation of the corresponding 2-methylthio benzodiazepine hydroiodide with an appropriate amine. The compounds are useful as antidepressants.
揭示了符合以下结构式的2-氨基-5-苯基-1,3-苯二氮杂环己烷类化合物:其中R.sub.1和R.sub.2分别为氢、卤素、烷基或烷氧基;R.sub.2能够占据芳香环上的任意位置;R.sub.3为氢或烷基;R.sub.4为氢、烷基、环烷基、芳基烷基、杂环芳基烷基、二烷基氨基乙基、二烷基氨基丙基、(1-乙基-2-吡咯啉基)甲基、烷氧羰基或氰基;或者R.sub.3和R.sub.4与相邻的氮原子形成含有5至7个侧链的杂环,侧链中可能含有另一个氧、硫或氮杂原子,后者能够被烷基基团取代。大多数化合物是通过将相应的2-甲硫基苯二氮杂环己烷类羟碘酸盐与适当的胺缩合而得到的。这些化合物可用作抗抑郁药物。